AstraZeneca sees positive results for Imfinzi in gastric cancers
(Alliance News) - AstraZeneca PLC on Friday reported positive results from planned interim analysis of a phase three trial evaluating its Imfinzi drug in gastric and gastroesophageal junction cancers. Read More